Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Johnson and Johnson
Colorcon
McKesson
Baxter

Last Updated: August 15, 2022

Investigational Drug Information for N91115


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug N91115?

N91115 is an investigational drug.

There have been 8 clinical trials for N91115. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2015.

The most common disease conditions in clinical trials are Cystic Fibrosis, Fibrosis, and Asthma. The leading clinical trial sponsors are Nivalis Therapeutics, Inc., Davita Clinical Research, and Medidata Solutions.

There are twenty-four US patents protecting this investigational drug and two hundred and seventy-two international patents.

Recent Clinical Trials for N91115
TitleSponsorPhase
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyUniversity of North Carolina, Chapel HillPhase 2
MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)Nivalis Therapeutics, Inc.Phase 1

See all N91115 clinical trials

Clinical Trial Summary for N91115

Top disease conditions for N91115
Top clinical trial sponsors for N91115

See all N91115 clinical trials

US Patents for N91115

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
N91115 See Plans and Pricing Modulators of cystic fibrosis transmembrane conductance regulator protein AbbVie S.a.r.l. (Luxembourg, LU) Galapagos NV (Mechelen, BE) See Plans and Pricing
N91115 See Plans and Pricing Heteroaryl substituted pyridines and methods of use AbbVie S.a.r.l. (Luxembourg, LU) Galapagos NV (Mechelen, BE) See Plans and Pricing
N91115 See Plans and Pricing N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use AbbVie S.a.r.l. (Luxembourg, LU) Galapagos NV (Mechelen, BE) See Plans and Pricing
N91115 See Plans and Pricing Substituted pyrrolidines and methods of use AbbVie S.a.r.l. (Luxembourg, LU) Galapagos NV (Mechelen, BE) See Plans and Pricing
N91115 See Plans and Pricing Solid forms of an S-Nitrosoglutathione reductase inhibitor LAUREL THERAPEUTICS LTD. (Hangzhou, Zhejiang Province, CN) See Plans and Pricing
N91115 See Plans and Pricing Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use AbbVie S.a.r.l. (Luxembourg, LU) Galapagos NV (Mechelen, BE) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for N91115

Drugname Country Document Number Estimated Expiration Related US Patent
N91115 Australia AU2017256172 2036-04-26 See Plans and Pricing
N91115 Brazil BR112018072047 2036-04-26 See Plans and Pricing
N91115 Canada CA3016303 2036-04-26 See Plans and Pricing
N91115 China CN109219602 2036-04-26 See Plans and Pricing
N91115 European Patent Office EP3448842 2036-04-26 See Plans and Pricing
N91115 Japan JP2019514840 2036-04-26 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Johnson and Johnson
Colorcon
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.